The present study was performed to evaluate the level of some risk factors (biochemical and immunological) in hypothyroid Iraqi patients considering the different thyroid functional states (hypothyroidism and subclinical hypothyroidism).The study includes 82 patients clinically diagnosed with hypothyroidism. Three study groups have been investigated: (47 clinical hypothyroid patients, 12 subclinical hypothyroid patients 23 healthy individuals) of different ages. This study, show that the proportion of females (83.3 %), (87.2%) in subclinical and clinical hypothyroidisim respectively higher than the proportion of males (16.7%),(12.8%) in subclinical and clinical hypothyrodism respectively of the total patients.The majority of subclinical hypothyroidism patients were found to be obese (61.7%) followed by normal weight class (21.3%).While in the case of clinical hypothyroidism the majority of patients are from the class of normal weight (66.7%) followed by over weight class (33.3%). The statistical study showed no significant differences in the TSH level between the weight categories among each of the studied groups, but the weight between 25-29.9 kg/m2 showed a highly significant increase and a significant increase in the level of TSH in the clinical and subclinical cases in comparison to its level in the healthy group. No significant differences were found in the level of HDL cholesterol (Good cholesterol) and triglyceride among the patient,s groups in comparison with its level of the control LDL cholesterol (Bad cholesterol) level increased in the subclinical and the clinical hypothyroid patients in comparison with its level in the healthy group, statistical analysis showed no significant differences in LDL–C. level between the subclinical and healthy groups. In contrast, there is a significant difference in LDL–C. level between clinical and healthy groups.The same relationships were noticed in the total chol. level and atherogenic agent.(nonsignificant increase in the subclinical hypothyroid patients and a significant increase in the clinical cases in comparison with its level in the healthy persons). No significant differences were found in the level of IL12 and IL-33 between the studied groups. Serum IL-33 level was lower in subclinical hypothyroid patients in comparison to its level in the other groups. In conclusion, as long as cholesterol and TSH continue high, the patients become more susceptible to coronary heart disease as proved through calculating atherogenic agent in each group. According to the positive relationship between thyroid hormones and IL-12, the latter may act as immunomodulating agents. The decrease of IL-33 in subclinical hypothyroid group suggests humeral immunological failure which may need more studies and evaluating for the other related cytokines.